PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: GlobeNewswire
MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General Manager for the company’s Asia-Pacific region. Jason will be responsible for leading and developing PacBio’s commercial team in Asia-Pacific as the company continues to expand its reach in the region to support rapidly growing demand for HiFi sequencing. Kang brings more than 25 years of global experience in the genomics industry to PacBio, having led Illumina’s Korean commercial operations for six years before launching Helixrus, which specializes in distributing large scale populational genomics and clinical sequencing software solutions in single-cell RNA and rare diseases. Prior to Helixrus and Illumina, Kang held various sales, marketing, and product development leadership roles at Life Technologies, Macrogen, and Spectral Genomics. “We’re delighted Jason is joining us in our mission t
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- PacBio moved to Neutral at JPMorgan after guidance cut [Seeking Alpha]Seeking Alpha
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.MarketBeat
PACB
Earnings
- 2/15/24 - Beat
PACB
Sec Filings
- 4/16/24 - Form 8-K
- 4/15/24 - Form PRE
- 4/11/24 - Form POSASR
- PACB's page on the SEC website